New hope for tough leukemia: trial tests Triple-Threat drug combo
NCT ID NCT07133997
Summary
This early-phase study is testing whether a combination of three drugs is safe and effective for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL) that has come back or hasn't responded to previous treatments. The trial will enroll about 26 participants to find the best dose and see if the drug combo can help put the cancer into remission. The main goal is to check for side effects and see if patients can tolerate the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.